OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats
Silje Skrede, Johan Fernø, María J. Vázquez, et al.
The International Journal of Neuropsychopharmacology (2011) Vol. 15, Iss. 2, pp. 163-179
Open Access | Times Cited: 78

Showing 26-50 of 78 citing articles:

Exploring the therapeutic potential of chlorogenic acid in alleviating olanzapine-induced metabolic syndrome in rats: a key role of hypothalamic satiety proteins
Zeinab Ebrahimian, Bibi Marjan Razavi, Seyed Ali Mousavi Shaegh, et al.
Nutritional Neuroscience (2025), pp. 1-20
Closed Access

Modelling olanzapine-induced weight gain in rats
Esther M. van der Zwaal, Sanna K. Janhunen, Susanne E. la Fleur, et al.
The International Journal of Neuropsychopharmacology (2013) Vol. 17, Iss. 01, pp. 169-186
Closed Access | Times Cited: 40

Metabolic Side-Effects of the Novel Second-Generation Antipsychotic Drugs Asenapine and Iloperidone: A Comparison with Olanzapine
Heidi N. Boyda, Ric M. Procyshyn, Catherine C.Y. Pang, et al.
PLoS ONE (2013) Vol. 8, Iss. 1, pp. e53459-e53459
Open Access | Times Cited: 39

Olanzapine depot exposure in male rats: Dose-dependent lipogenic effects without concomitant weight gain
Johan Fernø, Kari M. Ersland, I.H. Duus, et al.
European Neuropsychopharmacology (2015) Vol. 25, Iss. 6, pp. 923-932
Closed Access | Times Cited: 38

Atypical Antipsychotics and the Risk of Hyperlipidemia: A Sequence Symmetry Analysis
Yoshinori Takeuchi, Kazuhiro Kajiyama, Chieko Ishiguro, et al.
Drug Safety (2015) Vol. 38, Iss. 7, pp. 641-650
Closed Access | Times Cited: 34

Effects of second-generation antipsychotics on human subcutaneous adipose tissue metabolism
Assel Sarsenbayeva, Cátia M. Marques-Santos, Ketan Thombare, et al.
Psychoneuroendocrinology (2019) Vol. 110, pp. 104445-104445
Open Access | Times Cited: 33

Olanzapine-depot administration induces time-dependent changes in adipose tissue endocrine function in rats
Kateřina Horská, Jana Kučerová, Zuzana Babinská, et al.
Psychoneuroendocrinology (2016) Vol. 73, pp. 177-185
Closed Access | Times Cited: 32

Adipose tissue as a target for second-generation (atypical) antipsychotics: A molecular view
Vítor Ferreira, Diana Grajales, Ángela M. Valverde
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2019) Vol. 1865, Iss. 2, pp. 158534-158534
Open Access | Times Cited: 32

Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model
Kateřina Horská, Silje Skrede, Jan Kučera, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 3

Effects of olanzapine on the elevation of macrophage infiltration and pro-inflammatory cytokine expression in female rats
Qingsheng Zhang, Meng Xiao He, Chao Deng, et al.
Journal of Psychopharmacology (2014) Vol. 28, Iss. 12, pp. 1161-1169
Open Access | Times Cited: 33

The Wnt Signaling Pathway Effector TCF7L2 Mediates Olanzapine-Induced Weight Gain and Insulin Resistance
Ranran Li, Jianjun Ou, Li Li, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 29

Olanzapine-induced nonalcoholic fatty liver disease: The effects of differential food pattern and the involvement of PGRMC1 signaling
Zhenyu Zhu, Ting Cao, Hui Chen, et al.
Food and Chemical Toxicology (2023) Vol. 176, pp. 113757-113757
Closed Access | Times Cited: 8

Acute effects of oral olanzapine treatment on the expression of fatty acid and cholesterol metabolism-related gene in rats
Xuemei Liu, Chao Deng, Shuang Cao, et al.
Life Sciences (2015) Vol. 128, pp. 72-78
Closed Access | Times Cited: 27

Early insulin resistance predicts weight gain and waist circumference increase in first-episode psychosis – A one year follow-up study
Jaakko Keinänen, Outi Mantere, Tuula Kieseppä, et al.
Schizophrenia Research (2015) Vol. 169, Iss. 1-3, pp. 458-463
Closed Access | Times Cited: 26

Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice
Megan Beauchemin, Ramaz Geguchadze, Anyonya R. Guntur, et al.
Pharmacological Research (2019) Vol. 152, pp. 104589-104589
Open Access | Times Cited: 24

Long-term administration of olanzapine induces adiposity and increases hepatic fatty acid desaturation protein in female C57BL/6J mice.
Po‐Hsun Hou, Geng‐Ruei Chang, Chin-Pin Chen, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2018) Vol. 21, Iss. 5, pp. 495-501
Closed Access | Times Cited: 23

An Evaluation of the Effects of the Novel Antipsychotic Drug Lurasidone on Glucose Tolerance and Insulin Resistance: A Comparison with Olanzapine
Claire Wu, Jessica W. Y. Yuen, Heidi N. Boyda, et al.
PLoS ONE (2014) Vol. 9, Iss. 9, pp. e107116-e107116
Open Access | Times Cited: 20

One-Year Treatment with Olanzapine Depot in Female Rats: Metabolic Effects
Kari M. Ersland, Lene Secher Myrmel, Even Fjære, et al.
The International Journal of Neuropsychopharmacology (2019) Vol. 22, Iss. 5, pp. 358-369
Open Access | Times Cited: 18

Antipsychotic-induced increase in lipid biosynthesis: activation through inhibition?
Silje Skrede, Vidar M. Steen, Johan Fern⊘
Journal of Lipid Research (2012) Vol. 54, Iss. 2, pp. 307-309
Open Access | Times Cited: 20

Aripiprazole-induced adverse metabolic alterations in polyI:C neurodevelopmental model of schizophrenia in rats
Kateřina Horská, Jana Kučerová, Eva Dražanová, et al.
Neuropharmacology (2017) Vol. 123, pp. 148-158
Closed Access | Times Cited: 18

Lack of Ovarian Secretions Reverts the Anabolic Action of Olanzapine in Female Rats
Silje Skrede, Ismael González‐García, Luís Martins, et al.
The International Journal of Neuropsychopharmacology (2017) Vol. 20, Iss. 12, pp. 1005-1012
Open Access | Times Cited: 18

Subchronic olanzapine exposure leads to increased expression of myelination-related genes in rat fronto-medial cortex
Kari M. Ersland, Silje Skrede, C. T. Stansberg, et al.
Translational Psychiatry (2017) Vol. 7, Iss. 11
Open Access | Times Cited: 18

Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation
Kateřina Horská, Hana Kotolová, Michal Karpíšek, et al.
Toxicology and Applied Pharmacology (2020) Vol. 406, pp. 115214-115214
Closed Access | Times Cited: 15

Antipsychotic-induced metabolic effects in the female rat: Direct comparison between long-acting injections of risperidone and olanzapine
Kari M. Ersland, Silje Skrede, Therese H. Røst, et al.
Journal of Psychopharmacology (2015) Vol. 29, Iss. 12, pp. 1280-1289
Closed Access | Times Cited: 15

Scroll to top